Development and optimisation of photonic crystal based nanosensors
| dc.check.embargoformat | Not applicable | en |
| dc.check.info | No embargo required | en |
| dc.check.opt-out | Not applicable | en |
| dc.check.reason | No embargo required | en |
| dc.check.type | No Embargo Required | |
| dc.contributor.advisor | O'Riordan, Alan | en |
| dc.contributor.author | Mitchell, Micki | |
| dc.contributor.funder | European Union | en |
| dc.date.accessioned | 2016-07-01T11:39:12Z | |
| dc.date.available | 2016-07-01T11:39:12Z | |
| dc.date.issued | 2016 | |
| dc.date.submitted | 2016 | |
| dc.description.abstract | This thesis involved the development of two Biosensors and their associated assays for the detection of diseases, namely IBR and BVD for veterinary use and C1q protein as a biomarker to pancreatic cancer for medical application, using Surface Plasmon Resonance (SPR) and nanoplasmonics. SPR techniques have been used by a number of groups, both in research [1-3] and commercially [4, 5] , as a diagnostic tool for the detection of various biomolecules, especially antibodies [6-8]. The biosensor market is an ever expanding field, with new technology and new companies rapidly emerging on the market, for both human [8] and veterinary applications [9, 10]. In Chapter 2, we discuss the development of a simultaneous IBR and BVD virus assay for the detection of antibodies in bovine serum on an SPR-2 platform. Pancreatic cancer is the most lethal cancer by organ site, partially due to the lack of a reliable molecular signature for diagnostic testing. C1q protein has been recently proposed as a biomarker within a panel for the detection of pancreatic cancer. The third chapter discusses the fabrication, assays and characterisation of nanoplasmonic arrays. We will talk about developing C1q scFv antibody assays, clone screening of the antibodies and subsequently moving the assays onto the nanoplasmonic array platform for static assays, as well as a custom hybrid benchtop system as a diagnostic method for the detection of pancreatic cancer. Finally, in chapter 4, we move on to Guided Mode Resonance (GMR) sensors, as a low-cost option for potential use in Point-of Care diagnostics. C1q and BVD assays used in the prior formats are transferred to this platform, to ascertain its usability as a cost effective, reliable sensor for diagnostic testing. We discuss the fabrication, characterisation and assay development, as well as their use in the benchtop hybrid system. | en |
| dc.description.sponsorship | European Union (Framework 7) | en |
| dc.description.status | Not peer reviewed | en |
| dc.description.version | Accepted Version | |
| dc.format.mimetype | application/pdf | en |
| dc.identifier.citation | Mitchell, M. 2016. Development and optimisation of photonic crystal based nanosensors. PhD Thesis, University College Cork. | en |
| dc.identifier.endpage | 179 | en |
| dc.identifier.uri | https://hdl.handle.net/10468/2819 | |
| dc.language.iso | en | en |
| dc.publisher | University College Cork | en |
| dc.rights | © 2016, Micki Mitchell. | en |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ | en |
| dc.subject | Bioplasmonics | en |
| dc.subject | Diagnostics | en |
| dc.subject | Label-free | en |
| dc.subject | Nanoarrays | en |
| dc.subject | Pancreatic cancer | en |
| dc.subject | Biosensor | en |
| dc.thesis.opt-out | false | |
| dc.title | Development and optimisation of photonic crystal based nanosensors | en |
| dc.type | Doctoral thesis | en |
| dc.type.qualificationlevel | Doctoral | en |
| dc.type.qualificationname | PhD (Science) | en |
| ucc.workflow.supervisor | alan.oriordan@tyndall.ie |
